The latest price target for Merit Medical Systems (NASDAQ:MMSI) was reported by Piper Sandler on January 29, 2025. The analyst firm set a price target for $116.00 expecting MMSI to rise to within 12 months (a possible 12.45% upside). 40 analyst firms have reported ratings in the last year.

The latest analyst rating for Merit Medical Systems (NASDAQ:MMSI) was provided by Piper Sandler, and Merit Medical Systems reiterated their overweight rating.

The last upgrade for Merit Medical Systems Inc happened on December 11, 2024 when Wells Fargo raised their price target to $120. Wells Fargo previously had an equal-weight for Merit Medical Systems Inc.

The last downgrade for Merit Medical Systems Inc happened on December 20, 2022 when Canaccord Genuity changed their price target from N/A to $72 for Merit Medical Systems Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Merit Medical Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Merit Medical Systems was filed on January 29, 2025 so you should expect the next rating to be made available sometime around January 29, 2026.

While ratings are subjective and will change, the latest Merit Medical Systems (MMSI) rating was a reiterated with a price target of $114.00 to $116.00. The current price Merit Medical Systems (MMSI) is trading at is $103.16, which is out of the analyst’s predicted range.